Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Y Dirix

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trialM Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancerX Bich Trinh, P A van Dam, P B Vermeulen, et al.
British Journal of Cancer|October 27, 2004
Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancerI H Benoy, H Elst, I Van der Auwera, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationP B Vermeulen, G Gasparini, S B Fox, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastasesR E Coleman, L Y Dirix, D Dodwell, et al.
British Journal of Cancer|November 23, 2006
First international consensus on the methodology of lymphangiogenesis quantification in solid human tumoursI Van der Auwera, Y Cao, J C Tille, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic studyH J Groen, E G de Vries, W Wynendaele, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2011
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignanciesR Thertulien, G M Manikhas, L Y Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2015
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trialD B Y Fontein, M Klinten Grand, J W R Nortier, et al.
Pathology, Research and Practice|October 23, 2002
Comparative analysis of the biochemical and immunohistochemical determination of hormone receptors in invasive breast carcinoma influence of the tumor-stroma ratioG G G M Van den Eynden, C G Colpaert, P B Vermeulen, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trialM Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancerX Bich Trinh, P A van Dam, P B Vermeulen, et al.
British Journal of Cancer|October 27, 2004
Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancerI H Benoy, H Elst, I Van der Auwera, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationP B Vermeulen, G Gasparini, S B Fox, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastasesR E Coleman, L Y Dirix, D Dodwell, et al.
British Journal of Cancer|November 23, 2006
First international consensus on the methodology of lymphangiogenesis quantification in solid human tumoursI Van der Auwera, Y Cao, J C Tille, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic studyH J Groen, E G de Vries, W Wynendaele, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2011
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignanciesR Thertulien, G M Manikhas, L Y Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2015
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trialD B Y Fontein, M Klinten Grand, J W R Nortier, et al.
Pathology, Research and Practice|October 23, 2002
Comparative analysis of the biochemical and immunohistochemical determination of hormone receptors in invasive breast carcinoma influence of the tumor-stroma ratioG G G M Van den Eynden, C G Colpaert, P B Vermeulen, et al.
Pageof 11